Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis

Journal of Medical Virology

Volumn 82, Issue 6, 2010, Pages 949-957

  Valva, Pamela ^a   De Matteo, Elena ^a   Galoppo, María C ^a   Gismondi, María I ^a   Preciado, María V ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Activated caspase 3; M30; TUNEL

Indexed keywords

ACTIVATED CASPASE 3; CASPASE 3; CYTOKERATIN 18; NONSTRUCTURAL PROTEIN 3; PROTEIN M30; UNCLASSIFIED DRUG;

ADOLESCENT; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNODETECTION; LIVER BIOPSY; LIVER FIBROSIS; MALE; NICK END LABELING; PATHOGENESIS; PREDICTION; PROTEIN BLOOD LEVEL;

ADOLESCENT; APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY; CASPASE 3; CHILD; CHILD, PRESCHOOL; FAT NECROSIS; FEMALE; HEPATITIS C, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFANT; KERATIN-18; LIVER; MALE; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 77953533816     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21699     Document Type: Article

References (45)

1. Afdhal N, Nunes D. 2004. Evaluation of liver fibrosis: A concise review. Am J Gastroenterol 99:1160-1174.
2. Badizadegan K, Jonas M, Ott M, Nelson S, Perez-Atayde A. 1998. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 28:1416-1423. (Pubitemid 28493855)
3. Bantel H, Lügering A, Heidemann J, Volkmann X, Poremba C, Strassburg C, Manns M, Schulze-Osthoff K. 2004a. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40: 1078-1087.
4. Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K. 2001. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34:758-767.
5. Bantel H, Ruck P, Gregor M, Schulze-Osthoff KM. 2004b. Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol 80:230-239. (Pubitemid 32241930)
6. Bantel H, Schulze-Osthoff K. 2003. Apoptosis in hepatitis C virus infection. Cell Death Differ 10:S48-58.
7. Cohen G. 1997. Caspases: The executioners of apoptosis. Biochem J 326:1-16.
8. Cross T, Quaglia A, Hughes S, Joshi D, Harrison P. 2009. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. J Viral Hepat 16:492-499.
9. Diab D, Yerian L, Schauer P, Kashyap S, Lopez R, Hazen S, Feldstein A. 2008. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol 6:1249-1254.
10. El-Zayadi A. 2008. Hepatic steatosis: A benign disease or a silent killer. World J Gastroenterol 14:4120-4126.
11. Fischer R, Baumert T, Blum H. 2007. Hepatitis C virus infection and apoptosis. World J Gastroenterol 13:4865-4872.
12. Fischer U, Jänicke R, Schulze-Osthoff K. 2003. Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 10:76-100.
13. Ghavami S, Hashemi M, Kadkhoda K, Alavian S, Bay GML. 2005. Apoptosis in liver diseases - Detection and therapeutic applications. Med Sci Monit 11:337-345. (Pubitemid 41695499)
14. Gismondi M, Turazza E, Grinstein S, Galoppo M, Preciado M. 2004. Hepatitis C virus infection in infants and children from Argentina. J Clin Microbiol 42:1199-1202.
15. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, Crivellaro C, Sokal E, Azzari C, Guido MFB. 2003. Chronic hepatitis C virus infection in childhood: Clinical patterns and evolution in 224 white children. Clin Infect Dis 36:275-280.
16. Kage M, Fujisawa T, Shiraki K, Tanaka T, Fujisawa T, Kimura A, Shimamatsu K, Nakashima E, Kojiro M, Koike M, Tazawa Y, Abukawa D, Okaniwa M, Takita H, Matsui A, Hayashi T, Etou T, Terasawa S, Sugiyama K, Tajiri H, Yoden A, Kajiwara Y, Sata MYU. 1997. Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology 26:771-775.
17. Kerr J, Cooksley W, Searle J, Halliday J, Halliday W, Holder L, Roberts I, Burnett W, Powell L. 1979. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 2:827-828. (Pubitemid 10205111)
18. Kronenberger B, Rüster B, Lee J, Sarrazin C, Roth W, Herrmann G, Zeuzem S. 2000. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. J Hepatol 33:640-647.
19. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
20. Leers M, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers F, Bjorklund B, Nap M, Jornvall H, Schutte B. 1999. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187:567-572.
21. MacFarlane M, Merrison W, Dinsdale D, Cohen G. 2000. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol 148:1239-1254.
22. McPartland J, Guzail M, Kendall C, Pringle J. 2005. Apoptosis in chronic viral hepatitis parallels histological activity: An immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody. Int J Exp Pathol 86:19-24.
23. Mengshol J, Golden Mason L, Rosen H. 2007. Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4:622-634.
24. Murray K, Finn L, Taylor S, Seidel K, Larson A. 2005. Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr 41:634-638.
25. National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion. (2000). Body mass index-for-age percentiles [online]. Available at http://www.cdc.gov/ growthcharts.
26. Negro F. 2006. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol 12:6756-6765. (Pubitemid 44811395)
27. Nhan T, Liles W, Schwartz S. 2006. Physiological functions of caspases beyond cell death. Am J Pathol 169:729-737.
28. Patel T, Gores G. 1995. Apoptosis and hepatobiliary disease. Hepatology 21:1725-1741.
29. Que F, Gores G. 1996. Cell death by apoptosis: Basic concepts and disease relevance for the gastroenterologist. Gastroenterology 110:1238-1243.
30. Rodríguez-Iñigo E, Bartolomé J, de Lucas S, Manzarbeitia F, Pardo M, Arocena C, Gosálvez J, Oliva H, Carreño V. 1999. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol 154:1877-1881.
31. Rust C, Gores G. 2000. Apoptosis and liver disease. Am J Med 108:567-574.
32. Sanai F, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo A, Alameri H, Akbar H, Bzeizi K. 2008. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? Liver Int 28:1011-1018.
33. Schwerk C, Schulze-Osthoff K. 2003. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 66:1453-1458.
34. Sebastiani G, Vario A, Guido M, Alberti A. 2008. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat 15:212-218. (Pubitemid 351143742)
35. Seidel N, Volkmann X, Langer F, Flemming P, Manns M, Schulze-Osthoff K, Bantel H. 2005. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology 42:113-120.
36. Simmonds P, Holmes E, Cha T, Chan S, McOmish F, Irvine B, Beall E, Yap P, Kolberg J, Urdea M. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399. (Pubitemid 23332300)
37. Theise ND, Bordenheimer HC, Ferrel LD. 2007. Acute and chronic viral hepatitis. In: Burt AD, Portmann BC, Ferrel LD, editors. MacSweens Pathology of the liver, Vol. 8, 5th edition. London: Churchill-Livingstone. pp 418-419.
38. Thompson C. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
39. Valva P, De Matteo E, Galoppo M, Pedreira A, Giacove G, Lezama C, Marco I, Galoppo M, Preciado M. 2008. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Hum Pathol 39:1816-1822.
40. Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns M, Schulze-Osthoff K, Bantel H. 2006. Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection. Hepatology 43:1311-1316.
41. Walsh MJVD, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. 2004. Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology 39:1230-1238.
42. Wieckowska A, Zein N, Yerian L, Lopez A, McCullough A, Feldstein A. 2006. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44:27-33.
43. Wyllie A, Kerr J, Currie A. 1980. Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
44. Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak S. 2007. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 13:837-844.
45. Zeuzem S, Alberti A, Rosenberg W, Marcellin P, Diago M, Negro F, Prati D, Puoti C, Roberts S, Shiffman M. 2006. Review article: Management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity. Aliment Pharmacol Ther 24:1133-1149.